Literature DB >> 6667101

Elimination and pharmacological effects following single oral doses of 50 and 75 mg of amitriptyline in man.

P Schulz, A E Balant-Gorgia, A Kubli, C Gertsch-Genet, G Garrone.   

Abstract

In a companion paper we described the disposition of a 75 mg single dose of amitriptyline in normal volunteers who were phenotyped as extensive or poor metabolizers of debrisoquine and bufuralol, and had a four-fold range in the oral clearance of the antidepressant, 50 mg of amitriptyline was also administered to the same volunteers. This paper compares the results after both doses and suggests that the disposition of amitriptyline is linear even in subjects with a low oral clearance. There was no relation between the pharmacokinetic data and the intensity of sedation or of psychomotor impairment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6667101     DOI: 10.1007/bf00342785

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr (1970)


  5 in total

1.  [French translation of the Stanford Sleepiness Scale and use of this scale of sedation following a single dose of midazolam or amitriptyline].

Authors:  P Schulz; A Walser; J J Meyer; A Kubli; G Garrone
Journal:  Agressologie       Date:  1983-09

2.  Single dose prediction of steady state plasma levels of amitriptyline.

Authors:  S Madakasira; S H Preskorn; R Weller; M Pardo
Journal:  J Clin Psychopharmacol       Date:  1982-04       Impact factor: 3.153

3.  Role of oxidation polymorphism on blood and urine concentrations of amitriptyline and its metabolites in man.

Authors:  A E Balant-Gorgia; P Schulz; P Dayer; L Balant; A Kubli; C Gertsch; G Garrone
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1982

4.  The genetic control of bufuralol metabolism in man.

Authors:  P Dayer; L Balant; F Courvoisier; A Kupfer; A Kubli; A Gorgia; J Fabre
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Jan-Mar       Impact factor: 2.441

5.  Neuropharmacological properties of amitriptyline, nortriptyline and their metabolites.

Authors:  J Hyttel; A V Christensen; B Fjalland
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1980-07
  5 in total
  2 in total

Review 1.  Discrepancies between pharmacokinetic studies of amitriptyline.

Authors:  P Schulz; P Dick; T F Blaschke; L Hollister
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

Review 2.  Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons.

Authors:  Nadine Beckmann; Deepa Sharma; Erich Gulbins; Katrin Anne Becker; Bärbel Edelmann
Journal:  Front Physiol       Date:  2014-09-02       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.